Efficacy and safety of zuranolone in major depressive disorder: a meta-analysis of factor effect and dose-response analyses
Journal
EClinicalMedicine
Journal Volume
66
Date Issued
2023-12
Author(s)
Lin, Yu-Wei
Hung, Kuo-Chuan
Liang, Chih-Sung
Tseng, Ping-Tao
Lin, Pao-Yen
Chia-Cheng Lai, Edward
Hsu, Chih-Wei
Abstract
Zuranolone is recognised as a promising antidepressant agent. Our study aimed to investigate the efficacy and safety of zuranolone in treating major depressive disorder (MDD).
Subjects
DRMA; Depression; MDD; Postpartum; SAGE-217; Zuranolone
Publisher
The Lancet
Type
journal article